Zobrazeno 1 - 10
of 112
pro vyhledávání: '"M. de Forni"'
Autor:
J.P. Armand, P. Baille, M. de Forni, Ph. Rougier, J. Bonneterre, Michel Ducreux, P. Clouet, M. Dembak, A. Lebecq, C. Blanc, Antoine Adenis, F. Lefresne-Soulas
Publikováno v:
European Journal of Cancer. 36:1016-1025
The aim of this study was to evaluate the efficacy of docetaxel as first-line chemotherapy in patients with unresectable metastatic or locally advanced pancreatic adenocarcinoma and to further characterise the safety and pharmacokinetic profiles of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39d84efb0703515c7e2f64a21165b667
https://doi.org/10.1016/s0959-8049(00)00072-1
https://doi.org/10.1016/s0959-8049(00)00072-1
Autor:
L N Igwemezie, Marc Bonnay, J.P. Armand, D Abigerges, B Winograd, L Schacter, M. de Forni, Guy G. Chabot, C Terret, Sanjeev Kaul, J Ropers
Publikováno v:
Journal of Clinical Oncology. 14:2020-2030
PURPOSE The purpose of this study was to determine the bioavailability (F) of etoposide (E;VP-16) after oral administration of the water-soluble prodrug etoposide phosphate (EP;BMY-40481) during a phase I trial in cancer patients. PATIENTS AND METHOD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0901ce7759cd7bca4d948654e68d1ac1
https://doi.org/10.1200/jco.1996.14.7.2020
https://doi.org/10.1200/jco.1996.14.7.2020
Autor:
Patrice Herait, J.P. Armand, M. de Forni, Chauvergne J, A. Goupil, B. Chevallier, P. Cappelaere, Catherine Lhommé, R. Metz, N. Guiochet, Pierre Fumoleau, Ph. Chollet, M.A. Lentz, P. Kerbrat, H. Roche
Publikováno v:
European Journal of Cancer. 29:350-354
From 1986 to 1990, a multicentric phase II study was conducted with pirarubicin, a new semi-synthetic anthracyclin [4′- O -tetrahydropyranyl-adriamycin (THP)]. 87 patients with advanced gynaecological cancers were treated: epidermoid cervical carci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4678b344c6df5580f5c7e35adfaef351
https://doi.org/10.1016/0959-8049(93)90384-r
https://doi.org/10.1016/0959-8049(93)90384-r
Autor:
Etienne Chatelut, Henri Roché, M. de Forni, Georges Houin, Roland Bugat, Y. Plusquellec, Christine Chevreau, Pierre Canal, N. P. Johnson
Publikováno v:
Annals of Oncology. 2:217-221
Cisplatin and teniposide given by intraperitoneal (IP) route exert a synergistic therapeutic effect against ascitic P388 leukemia in mice. As single agents, they display different dose-limiting toxicities and favourable pharmacokinetic characteristic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a91b18d1fd56f21a82c120c8dc32ba
https://doi.org/10.1093/oxfordjournals.annonc.a057910
https://doi.org/10.1093/oxfordjournals.annonc.a057910
Autor:
P, Rougier, A, Adenis, M, Ducreux, M, de Forni, J, Bonneterre, M, Dembak, P, Clouet, A, Lebecq, P, Baille, F, Lefresne-Soulas, C, Blanc, J P, Armand
Publikováno v:
European journal of cancer (Oxford, England : 1990). 36(8)
The aim of this study was to evaluate the efficacy of docetaxel as first-line chemotherapy in patients with unresectable metastatic or locally advanced pancreatic adenocarcinoma and to further characterise the safety and pharmacokinetic profiles of d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7760e52ab20fd038befee65b9ff1808a
https://pubmed.ncbi.nlm.nih.gov/10885606
https://pubmed.ncbi.nlm.nih.gov/10885606
Publikováno v:
Bulletin du cancer. 86(7-8)
Consolidation treatment of advanced ovarian carcinoma, especially the place of intraperitoneal chemotherapy, remains a controversial subject. From January 1988 to July 1995, 39 patients, median age 54 years, received intraperitoneal chemotherapy as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::239c4c1400146a0e9691c7b2f56d6240
https://pubmed.ncbi.nlm.nih.gov/10477384
https://pubmed.ncbi.nlm.nih.gov/10477384
Autor:
C. Couteau, S. Bordessoule, J.P. Armand, S. Leyvraz, V. Groult, A. Lebecq, N. Chouaki, Christian Domenge, François Janot, M. de Forni, D. Oulid-Aissa
Publikováno v:
British Journal of Cancer, vol. 81, no. 3, pp. 457-462
British Journal of Cancer
British Journal of Cancer
This study was designed to evaluate the activity, safety and tolerance of docetaxel (D) in a selected population with metastatic squamous cell carcinoma of the head and neck (SCCHN). Twenty-four patients with no prior palliative therapy were enrolled
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9b4641d4a5335fb79e9e4328b2ba45
https://serval.unil.ch/notice/serval:BIB_554804F9BCA7
https://serval.unil.ch/notice/serval:BIB_554804F9BCA7
Autor:
E. Tellez Bernal, T. Guillot, Cecil O. Borel, Bernard Luboinski, Gonzalo Recondo, Esteban Cvitkovic, Christian Domenge, François Janot, François Eschwege, M. de Forni, J.P. Armand, Mohamed-El-Amine Bensmaïne, Pierre Wibault
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 14(4)
PURPOSE To evaluate an intensive concomitant chemoradiotherapy protocol of conventional radiotherapy with intermittent cisplatin (CDDP) and continuous-infusion fluorouracil (5-FU) in unresectable, locally advanced squamous cell carcinoma of the head
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51da0f1b687180251a24f9560aecec50
https://pubmed.ncbi.nlm.nih.gov/8648374
https://pubmed.ncbi.nlm.nih.gov/8648374
Autor:
Michel Ducreux, Patrice Herait, Ph. Rougier, Guy G. Chabot, R. Bugat, M. de Forni, D Abigerges, J.P. Armand, M. Mahjoubi
Publikováno v:
European journal of cancer (Oxford, England : 1990). (7-8)
Colorectal cancer is one of the most common cancers in the Western World. Although 50% of patients are cured by surgery alone, the outcome is poor in high-risk patients (Dukes stages B2 and C) despite adjuvant chemotherapy with 5-fluorouracil (5-FU)-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a36743e52dfeb8aa018a65b6f8cb75aa
https://pubmed.ncbi.nlm.nih.gov/7577037
https://pubmed.ncbi.nlm.nih.gov/7577037
Autor:
Patrice Herait, G. Catimel, M. de Forni, Jean-Marc Extra, Roland Bugat, J.P. Armand, Guy G. Chabot, M. Mahjoubi, M. Clavel, Stéphane Culine, Michel Marty, D Abigerges
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 6(2)
Summary Background Irinotecan (CPT-11) is a novel water-soluble camptothecin derivative selected for clinical testing based on its good in vitro and in vivo activity in various experimental systems, including pleiotropic drug-resistant tumors. Its me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01639a1112a349451f96139913ca31f9
https://pubmed.ncbi.nlm.nih.gov/7786822
https://pubmed.ncbi.nlm.nih.gov/7786822